Other
Gain Loss On Fair Value Hedges Recognized In Earnings
West Pharmaceutical Services Gain Loss On Fair Value Hedges Recognized In Earnings increased by 200.0% to $1.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 200.0%, from $400K to $1.2M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_gain_loss_on_fair_value_hedges_recognized_in_earningsHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$600K | -$900K | -$800K | -$1.4M | -$2.2M | -$1.2M | $900K | $2M | $1.8M | $1.7M | $1.8M | $400K | $500K | $400K | $1.2M |
| QoQ Change | — | -50.0% | +11.1% | -75.0% | -57.1% | +45.5% | +175.0% | +122.2% | -10.0% | -5.6% | +5.9% | -77.8% | +25.0% | -20.0% | +200.0% |
| YoY Change | — | — | — | -133.3% | -144.4% | -50.0% | +164.3% | +190.9% | +250.0% | +88.9% | -10.0% | -77.8% | -70.6% | -77.8% | +200.0% |
Range-$2.2M – $2M
CAGR+21.9%
Avg YoY Growth+27.5%
Median YoY Growth-30.0%
Frequently Asked Questions
- What is West Pharmaceutical Services's gain loss on fair value hedges recognized in earnings?
- West Pharmaceutical Services (WST) reported gain loss on fair value hedges recognized in earnings of $1.2M in Q1 2026.
- How has West Pharmaceutical Services's gain loss on fair value hedges recognized in earnings changed year-over-year?
- West Pharmaceutical Services's gain loss on fair value hedges recognized in earnings increased by 200.0% year-over-year, from $400K to $1.2M.